Journal article
Milk thistle and indinavir: A randomized controlled pharmacokinetics study and meta-analysis
European Journal of Clinical Pharmacology, Vol.61(1), pp.1-7
2005
Abstract
Objectives
To determine whether ingestion of milk thistle affects the pharmacokinetics of indinavir.
Methods
We conducted a three-period, randomized controlled trial with 16 healthy participants. We randomized participants to milk thistle or control. All participants received initial dosing of indinavir, and baseline indinavir levels were obtained (AUC0-8) (phase I). The active group were then given 450 mg milk-thistle extract capsules to be taken t.i.d. from day 2 to day 30. The control group received no plant extract. On day 29 and day 30, indinavir dosing and sampling was repeated in both groups as before (phase II). After a wash-out period of 7 days, indinavir dosing and sampling were repeated as before (phase III).
Results
All participants completed the trial, but two were excluded from analysis due to protocol violation. There were no significant between-group differences. Active group mean AUC0-8 indinavir decreased by 4.4% (90% CI, −27.5% to −26%, P=0.78) from phase I to phase II in the active group, and by 17.3% (90% CI, −37.3% to +9%, P=0.25) in phase III. Control group mean AUC0-8 decreased by 21.5% (90% CI, −43% to +8%, P=0.2) from phase I to phase II and by 38.5% (90% CI, −55.3% to −15.3%, P=0.01) of baseline at phase III. To place our findings in context, milk thistle–indinavir trials were identified through systematic searches of the literature. A meta-analysis of three milk thistle–indinavir trials revealed a non-significant pooled mean difference of 1% in AUC0-8 (95% CI, −53% to 55%, P=0.97).
Conclusions
Indinavir levels were not reduced significantly in the presence of milk thistle.
Details
- Title
- Milk thistle and indinavir: A randomized controlled pharmacokinetics study and meta-analysis
- Authors/Creators
- E. Mills (Author/Creator) - McMaster-CarrK. Wilson (Author/Creator) - University of TorontoM. Clarke (Author/Creator) - CochraneB. Foster (Author/Creator) - Health CanadaS. Walker (Author/Creator) - Women's College HospitalB. Rachlis (Author/Creator) - Canadian College of Naturopathic MedicineN. DeGroot (Author/Creator) - Canadian College of Naturopathic MedicineV.M. Montori (Author/Creator) - Mayo ClinicW. Gold (Author/Creator) - University of TorontoE. Phillips (Author/Creator) - Women's College HospitalS. Myers (Author/Creator) - The University of QueenslandK. Gallicano (Author/Creator) - Watson Laboratories
- Publication Details
- European Journal of Clinical Pharmacology, Vol.61(1), pp.1-7
- Publisher
- Springer-Verlag
- Identifiers
- 991005546015607891
- Copyright
- 2005 Springer-Verlag
- Murdoch Affiliation
- Murdoch University
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
19 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.117 Pharmacology & Toxicology
- 1.117.179 Cytochrome P450
- Web Of Science research areas
- Pharmacology & Pharmacy
- ESI research areas
- Pharmacology & Toxicology